Fresenius bonds and loans in doubt as Rhön-Klinikum deal halted
The takeover of Rhön-Klinikum by German health care group Fresenius has come to a halt, after not enough Rhön-Klinikum shareholders backed the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
